__NUXT_JSONP__("/drugs/Dulanermin", (function(a,b){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"867153-61-5",chebiId:"",chemicalFormula:"C871H1329N243O260S4",definition:"A recombinant human soluble protein corresponding to amino acids 114-281 of the Apo2 ligand\u002Ftumor necrosis factor-related apoptosis-inducing ligand (RhApo2L\u002FTRAIL) with potential antineoplastic activity. Dulanermin binds to and activates TRAIL receptors 1 and 2 (TRAIL-R1\u002FR2), which may activate caspases and induce p53-independent apoptosis in TRAIL-R1\u002FR2-expressing tumor cells. The pro-apoptotic cell surface receptors TRAIL-R1 and -R2, also known as DR4 (death receptor 4) and DR5 (death receptor 5), are members of the TNF receptor family and are overexpressed by a variety of cancer cell types.",fdaUniiCode:"L65E7T81M5",identifier:"C1685",preferredName:a,semanticType:"Amino Acid, Peptide, or Protein",subclassOf:["C1941"],synonyms:["114-281-protein TRAIL","AMG 951","APO2L\u002FTRAIL","DULANERMIN",a,"RG3639","rTRAIL"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FDulanermin",extension:".json",createdAt:b,updatedAt:b}}],fetch:{},mutations:void 0}}("Dulanermin","2021-10-30T13:35:52.213Z")));